{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:46:22Z","timestamp":1787010382875,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7,27]]},"DOI":"10.1097\/tp.0000000000000030","type":"journal-article","created":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T12:27:03Z","timestamp":1394627223000},"page":"187-194","source":"Crossref","is-referenced-by-count":44,"title":["Delayed-Onset Cytomegalovirus Disease Coded During Hospital Readmission After Kidney Transplantation"],"prefix":"10.1097","volume":"98","author":[{"given":"Carlos A. Q.","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria J.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.TP.0000148239.00384.F0","article-title":"Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients.","volume":"79","author":"Rowshani","year":"2005","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajt.12093","article-title":"Introduction: infections in solid organ transplantation.","volume":"13","author":"Green","year":"2013","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation.","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"key":"R4-12-20210129","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients.","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1523-1755.2004.00735.x","article-title":"Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival.","volume":"66","author":"Sagedal","year":"2004","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.tp.0000230460.42558.b0","article-title":"The natural course of cytomegalovirus infection and disease in renal transplant recipients.","volume":"82","author":"Hartmann","year":"2006","journal-title":"Transplantation"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1399-3062.2007.00241.x","article-title":"Clinical features and outcomes of cytomegalovirus retinitis after transplantation.","volume":"10","author":"Eid","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.transproceed.2011.11.053","article-title":"Cytomegalovirus disease in kidney transplant recipients: incidence, clinical profile, and risk factors.","volume":"44","author":"Cordero","year":"2012","journal-title":"Transplant Proc"},{"key":"R9-12-20210129","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/00007890-200010270-00007","article-title":"A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients.","volume":"70","author":"Sagedal","year":"2000","journal-title":"Transplantation"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalo virus disease in solid organ transplant recipients.","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/01.tp.0000204048.90367.97","article-title":"24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course.","volume":"81","author":"Doyle","year":"2006","journal-title":"Transplantation"},{"key":"R12-12-20210129","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","article-title":"Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients.","volume":"6","author":"Khoury","year":"2006","journal-title":"Am J Transplant"},{"key":"R13-12-20210129","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients.","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"key":"R14-12-20210129","first-page":"CD003774","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.","volume":"2","author":"Hodson","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R15-12-20210129","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1086\/324516","article-title":"Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.","volume":"184","author":"Razonable","year":"2001","journal-title":"J Infect Dis"},{"key":"R16-12-20210129","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/528718","article-title":"Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation.","volume":"46","author":"Arthurs","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R17-12-20210129","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/ndt\/gfn558","article-title":"Prospective follow-up of primary CMV infections after 6 months of valganciclovir prophylaxis in renal transplant recipients.","volume":"24","author":"Helantera","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R18-12-20210129","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1111\/j.1600-6143.2010.03225.x","article-title":"Primary CMV infections are common in kidney transplant recipients after 6 months valganciclovir prophylaxis.","volume":"10","author":"Helantera","year":"2010","journal-title":"Am J Transplant"},{"key":"R19-12-20210129","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1399-3062.2011.00646.x","article-title":"Epidemiology and risk factors for late infection in solid organ transplant recipients.","volume":"13","author":"Cervera","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"R20-12-20210129","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.transproceed.2004.07.017","article-title":"Late cytomegalovirus disease with atypical presentation in renal transplant patients: case reports.","volume":"36","author":"Boobes","year":"2004","journal-title":"Transplant Proc"},{"key":"R21-12-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-3062.2011.00705.x","article-title":"Risk factors and clinical outcomes of cytomegalovirus disease occurring more than one year post solid organ transplantation.","volume":"14","author":"Blyth","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"R22-12-20210129","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000239220","article-title":"Who is caring for kidney transplant patients Variation by region, transplant center, and patient characteristics.","volume":"30","author":"Israni","year":"2009","journal-title":"Am J Nephrol"},{"key":"R23-12-20210129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1399-3062.2011.00624.x","article-title":"Risk factors for late-onset cytomegalovirus disease in donor seropositiverecipient seronegative kidney transplant recipients who receive antiviral prophylaxis.","volume":"13","author":"Boudreault","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"R24-12-20210129","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/jmv.23539","article-title":"High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy.","volume":"85","author":"Harvala","year":"2013","journal-title":"J Med Virol"},{"key":"R26-12-20210129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-6143.2009.02861.x","article-title":"Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients.","volume":"10","author":"Eid","year":"2010","journal-title":"Am J Transplant"},{"key":"R27-12-20210129","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/10898540-000000000-00000","article-title":"New developments in the management of cytomegalovirus infection after solid organ transplantation.","volume":"70","author":"Eid","year":"2010","journal-title":"Drugs"},{"key":"R28-12-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000013592","article-title":"Cytomegalovirus-induced tubulointerstitial nephritis in a renal allograft treated by foscarnet therapy.","volume":"20","author":"Wong","year":"2000","journal-title":"Am J Nephrol"},{"key":"R29-12-20210129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-123-1-199507010-00002","article-title":"Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial.","volume":"123","author":"Hibberd","year":"1995","journal-title":"Ann Intern Med"},{"key":"R30-12-20210129","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archsurg.1995.01430110075014","article-title":"Preemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplants recipients.","volume":"130","author":"Conti","year":"1995","journal-title":"Arch Surg"},{"key":"R31-12-20210129","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1047-2797(01)00283-6","article-title":"Hospitalizations for cytomegalovirus disease after renal transplantation in the United States.","volume":"12","author":"Abbott","year":"2002","journal-title":"Ann Epidemiol"},{"key":"R32-12-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ajt.12060","article-title":"Measuring the disparity gap: quality improvement to eliminate health disparities in kidney transplantation.","volume":"13","author":"Patzer","year":"2013","journal-title":"Am J Transplant"},{"key":"R33-12-20210129","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneph.2012.117","article-title":"Influence of race, ethnicity and socioeconomic status on kidney disease.","volume":"8","author":"Patzer","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R35-12-20210129","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1128\/IAI.68.5.2925-2929.2000","article-title":"Impairment of endotoxin-induced macrophage inflammatory protein 2 gene expression in alveolar macrophages in streptozotocin-induced diabetes in mice.","volume":"68","author":"Amano","year":"2000","journal-title":"Infect Immun"},{"key":"R36-12-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V","article-title":"Impaired leucocyte functions in diabetic patients.","volume":"14","author":"Delamaire","year":"1997","journal-title":"Diabet Med"},{"key":"R37-12-20210129","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2337\/diabetes.49.9.1451","article-title":"Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like dbdb mice.","volume":"49","author":"Zykova","year":"2000","journal-title":"Diabetes"},{"key":"R38-12-20210129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/mgme.2001.3185","article-title":"Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes.","volume":"73","author":"Mazade","year":"2001","journal-title":"Mol Genet Metab"},{"key":"R39-12-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.imbio.2010.06.002","article-title":"High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus.","volume":"216","author":"Ilyas","year":"2011","journal-title":"Immunobiology"},{"key":"R40-12-20210129","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/j.1582-4934.2009.00803.x","article-title":"Methylglyoxal modulates immune responses: relevance to diabetes.","volume":"14","author":"Price","year":"2010","journal-title":"J Cell Mol Med"},{"key":"R41-12-20210129","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004.","volume":"50","author":"Bate","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R42-12-20210129","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients.","volume":"9","author":"Kumar","year":"2009","journal-title":"Am J Transplant"},{"key":"R43-12-20210129","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00007890-199403270-00015","article-title":"The impact of an acute rejection episode on long-term renal allograft survival (t12).","volume":"57","author":"Matas","year":"1994","journal-title":"Transplantation"},{"key":"R44-12-20210129","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/TP.0b013e3181661695","article-title":"Influence of time of rejection on long-term graft survival in renal transplantation.","volume":"85","author":"Opelz","year":"2008","journal-title":"Transplantation"},{"key":"R45-12-20210129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data.","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"R47-12-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model.","volume":"69","year":"1982","journal-title":"Biometrika"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000000030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:13:31Z","timestamp":1620962011000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201407270-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,27]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000000030","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7,27]]}}}